
Khatol S. Shahnan Shah
Examiner (ID: 11792, Phone: (571)272-0863 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 690 |
| Issued Applications | 340 |
| Pending Applications | 103 |
| Abandoned Applications | 265 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20171796
[patent_doc_number] => 12390516
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Vaccines against tick-borne diseases
[patent_app_type] => utility
[patent_app_number] => 16/631964
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7827
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631964
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/631964 | Vaccines against tick-borne diseases | Jul 16, 2018 | Issued |
Array
(
[id] => 13504689
[patent_doc_number] => 20180303887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => Algal Extract Comprising Sulphated And Non-Sulphated Polyanionic Polysaccharides And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/017862
[patent_app_country] => US
[patent_app_date] => 2018-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16017862
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/017862 | Algal extract comprising sulphated and non-sulphated polyanionic polysaccharides and uses thereof | Jun 24, 2018 | Issued |
Array
(
[id] => 13415955
[patent_doc_number] => 20180259520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => RAPID DUAL DIRECT FLUORESCENT ANTIBODY ASSAY FOR THE IDENTIFICATION OF BACILLUS ANTHRACIS
[patent_app_type] => utility
[patent_app_number] => 15/978479
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978479
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/978479 | Rapid dual direct fluorescent antibody assay for the identification of | May 13, 2018 | Issued |
Array
(
[id] => 16012729
[patent_doc_number] => 20200181207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => ANALYTICAL AND THERAPEUTIC METHODS AND COMPOSITIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/608651
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608651
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608651 | ANALYTICAL AND THERAPEUTIC METHODS AND COMPOSITIONS, AND USES THEREOF | Apr 25, 2018 | Abandoned |
Array
(
[id] => 15927967
[patent_doc_number] => 20200155617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => METHODS OF TREATING AND DIAGNOSING IBD ASSOCIATED WITH R. GNAVUS AND/OR R. GNAVUS GROUP IBD COLONIZATION
[patent_app_type] => utility
[patent_app_number] => 16/604866
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604866
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604866 | Methods of treating and diagnosing IBD associated with r. gnavus and/or r. gnavus group IBD colonization | Apr 19, 2018 | Issued |
Array
(
[id] => 13563189
[patent_doc_number] => 20180333142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => DEVICES AND METHODS FOR THE DETECTION OF AN INFECTION
[patent_app_type] => utility
[patent_app_number] => 15/954350
[patent_app_country] => US
[patent_app_date] => 2018-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15954350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/954350 | DEVICES AND METHODS FOR THE DETECTION OF AN INFECTION | Apr 15, 2018 | Abandoned |
Array
(
[id] => 17275842
[patent_doc_number] => 20210382040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => DETECTION OF BIOLOGICALS PENETRATION INTO TISSUE SURROGATES
[patent_app_type] => utility
[patent_app_number] => 17/288060
[patent_app_country] => US
[patent_app_date] => 2018-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288060 | DETECTION OF BIOLOGICALS PENETRATION INTO TISSUE SURROGATES | Mar 25, 2018 | Abandoned |
Array
(
[id] => 18328249
[patent_doc_number] => 11633466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Enteric fever vaccine based on outer membrane vesicles from two different strains of typhoidal
[patent_app_type] => utility
[patent_app_number] => 16/494947
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 5020
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494947 | Enteric fever vaccine based on outer membrane vesicles from two different strains of typhoidal | Mar 20, 2018 | Issued |
Array
(
[id] => 13481723
[patent_doc_number] => 20180292404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => ESCHERICHIA COLI O157:H7 APTAMER AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/927680
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927680
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/927680 | ESCHERICHIA COLI O157:H7 APTAMER AND APPLICATIONS THEREOF | Mar 20, 2018 | Abandoned |
Array
(
[id] => 18186677
[patent_doc_number] => 11577238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Testing for particulates
[patent_app_type] => utility
[patent_app_number] => 16/489853
[patent_app_country] => US
[patent_app_date] => 2018-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 40
[patent_no_of_words] => 21644
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489853
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489853 | Testing for particulates | Feb 27, 2018 | Issued |
Array
(
[id] => 15008497
[patent_doc_number] => 10450364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Hyperimmunized egg product for treatment of necrotic enteritis in poultry
[patent_app_type] => utility
[patent_app_number] => 15/895636
[patent_app_country] => US
[patent_app_date] => 2018-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 29
[patent_no_of_words] => 29124
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15895636
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/895636 | Hyperimmunized egg product for treatment of necrotic enteritis in poultry | Feb 12, 2018 | Issued |
Array
(
[id] => 18825286
[patent_doc_number] => 11840556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Modified nanopores, compositions comprising the same, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/484798
[patent_app_country] => US
[patent_app_date] => 2018-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 35
[patent_no_of_words] => 34172
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484798 | Modified nanopores, compositions comprising the same, and uses thereof | Feb 11, 2018 | Issued |
Array
(
[id] => 15861175
[patent_doc_number] => 20200137991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => FINDING AND TREATMENT OF INFLAMMATION AFTER BIRTH IN CHIMERIC ANIMAL
[patent_app_type] => utility
[patent_app_number] => 16/480169
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480169
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480169 | Finding and treatment of inflammation after birth in chimeric animal | Jan 24, 2018 | Issued |
Array
(
[id] => 15019247
[patent_doc_number] => 20190320628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => A NON-HUMAN ANIMAL MODEL OF NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/474647
[patent_app_country] => US
[patent_app_date] => 2017-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474647
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474647 | A NON-HUMAN ANIMAL MODEL OF NEURODEGENERATIVE DISORDERS | Dec 27, 2017 | Abandoned |
Array
(
[id] => 15405565
[patent_doc_number] => 20200023104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => DEVICES AND METHODS FOR WOUND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/471761
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471761
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471761 | DEVICES AND METHODS FOR WOUND TREATMENT | Dec 21, 2017 | Abandoned |
Array
(
[id] => 16389583
[patent_doc_number] => 20200330524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE
[patent_app_type] => utility
[patent_app_number] => 16/468343
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468343
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/468343 | AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE | Dec 11, 2017 | Abandoned |
Array
(
[id] => 19397315
[patent_doc_number] => 12071666
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Human genetic markers associated with response to treatments that target clostridium difficile toxin B
[patent_app_type] => utility
[patent_app_number] => 16/468982
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 21311
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468982
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/468982 | Human genetic markers associated with response to treatments that target clostridium difficile toxin B | Dec 6, 2017 | Issued |
Array
(
[id] => 15256435
[patent_doc_number] => 20190376951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => EX VIVO ANTIGEN AND ADJUVANT PULSED PERIPHERAL BLOOD MONONUCLEAR CELLS AS A SCREENING PLATFORM FOR CANDIDATE NOVEL VACCINES AND CANDIDATE ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 16/463704
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463704 | Ex vivo antigen and adjuvant pulsed peripheral blood mononuclear cells as a screening platform for candidate novel vaccines and candidate antigens | Dec 6, 2017 | Issued |
Array
(
[id] => 12786328
[patent_doc_number] => 20180153945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => ORAL E. COLI VECTOR-BASED VACCINE FOR PREVENTION OF COCCIDIOSIS IN POULTRY
[patent_app_type] => utility
[patent_app_number] => 15/828778
[patent_app_country] => US
[patent_app_date] => 2017-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15828778
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/828778 | ORAL E. COLI VECTOR-BASED VACCINE FOR PREVENTION OF COCCIDIOSIS IN POULTRY | Nov 30, 2017 | Abandoned |
Array
(
[id] => 15117271
[patent_doc_number] => 20190345268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => EXOPOLYSACCHARIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/465237
[patent_app_country] => US
[patent_app_date] => 2017-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465237
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/465237 | Exopolysaccharides and uses thereof | Nov 30, 2017 | Issued |